GENEVA, April 6 -- LG CHEM, LTD. (128, Yeoui-daeroYeongdeungpo-guSeoul 07336) filed a patent application (PCT/IB2024/000549) for "USE OF MELANOCORTIN-4 RECEPTOR AGONISTS FOR THE TREATMENT OF PCSK1 DEFICIENCY INDICATIONS" on Sep 27, 2024. With publication no. WO/2025/068770, the details related to the patent application was published on Apr 03, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): PARK, Hee, Dong (c/o LG Chem, Ltd.128, Yeoui-daeroYeongdeungpo-guSeoul 07336), HWANG, Hye, Kyeong (c/o LG Chem, Ltd.128, Yeoui-daeroYeongdeungpo-guSeoul 07336)
Abstract:
The present invention relates t...